Companies / Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc.
Nasdaq: EWTXCIK 1710072BOULDER, CO
Financials
Ownership
108.6M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 0.05% | 53,592 |
| Institutions | 114.06% | 123,879,074 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Fox Jonathan CDirector | 0.02% | 24,175 |
Edris BadreddinDirector | 0.02% | 19,820 |
| <0.01% | 9,597 | |
Brege LauraDirector | — | — |
Morris ArleneDirector | — | — |
Thompson Peter A.Director · 10% owner | — | — |
Institutional holders 204
View all →| Holder | Value | % of shares |
|---|---|---|
| $488.83M | 14.29% | |
| $328.50M | 9.60% | |
| $268.42M | 6.08% | |
| $207.14M | 6.05% | |
| $186.29M | 5.45% | |
| $168.53M | 4.93% | |
| $162.32M | 6.02% | |
| $139.36M | 4.07% | |
| $129.31M | 4.80% | |
| $120.89M | 4.49% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | — | $42.47M | +1.3M +29.53% | 5,915,556 5.45% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | — | $28.63M | +1.2M +359.25% | 1,474,797 1.36% of shares | medium |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | Exit | — | $-19.00M | -766K -100.00% | — | medium |
| Q1 2026 as of | Norges Bank 13F manager | Exit | — | $-18.64M | -751K -100.00% | — | medium |
| Q4 2025 as of | Norges Bank 13F manager | Add | — | $17.46M | +704K +1473.35% | 751,355 0.69% of shares | medium |
| Q1 2026 as of | AllianceBernstein L.P. 13F manager | Add | — | $17.02M | +686K +66.21% | 1,722,169 1.59% of shares | medium |
| Q1 2024 as of | Barclays PLC 13F manager | Trim | — | $-12.62M | -692K -88.80% | 87,244 0.08% of shares | medium |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Trim | — | $-9.13M | -290K -73.43% | 104,863 0.10% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Paradigm BioCapital Advisors LP | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EWTX | — | 28036F105 |